Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
---|
06/02/1998 | US5760175 Peptide to detect several herpes virus infections |
06/02/1998 | US5760072 Paclitaxel prodrugs, method for preparation as well as their use in selective chemotherapy |
06/02/1998 | US5759994 Antithrombin peptide for cardiovascular disorders |
06/02/1998 | US5759993 Modified sialyl Lewisx compounds |
06/02/1998 | US5759992 Immunotherapeutic agent derived from bacteria and method for its manufacture |
06/02/1998 | US5759841 Immunological composition of measles virus utilizing recombinant poxvirus |
06/02/1998 | US5759818 N-terminal CTP extended pharmaceutical peptides and proteins |
06/02/1998 | US5759814 Genetic engineering and dna for gene expression of glucosylated polypeptides in eukarotic host cells, oligonucleotide sequences, transcription and translational regulatory sequences and transformation |
06/02/1998 | US5759813 Methods and compositions relating to useful antigens of moraxella catarrhalis |
06/02/1998 | US5759808 Immunoglobulins devoid of light chains |
06/02/1998 | US5759804 Culture product |
06/02/1998 | US5759792 Antigenic regions of tumour-liberated particles (TLP) complexes and antibodies against the same |
06/02/1998 | US5759789 Prostaglandin receptor EP2 |
06/02/1998 | US5759783 Method of screening for cancer by detecting messenger RNA for a MAGE-XP gene |
06/02/1998 | US5759770 Retrovirus from the HIV group and its use |
06/02/1998 | US5759769 Diagnostic kits, vaccines; immobilized peptide having amino acid sequence epitope |
06/02/1998 | US5759572 Liposome with oligosaccharide on surface |
06/02/1998 | US5759554 Immunostimulatory bacterial cell wall traction |
06/02/1998 | US5759553 Polypeptides |
06/02/1998 | US5759552 Marek's disease virus recombinant poxvirus vaccine |
06/02/1998 | US5759551 Luteinizing hormone releasing hormone peptides that prevent growth of the prostate gland |
06/02/1998 | US5759546 Treatment of CD4 T-cell mediated conditions |
06/02/1998 | US5759536 Use of fas ligand to supress T-lymphocyte-mediated immune responses |
06/02/1998 | US5759535 Immunotherapeutic strategies for the treatment of cancer |
06/02/1998 | US5759514 Composition for delivery of toxic radioisotopes to the cell nucleus and use |
05/28/1998 | WO1998022605A1 Improved methods for transducing cells |
05/28/1998 | WO1998022589A2 Survivin, a protein that inhibits cellular apoptosis, and its modulation |
05/28/1998 | WO1998022580A2 Bovine lactation associated immunotropic protein (cd14), encoding gene and application in b cell activation |
05/28/1998 | WO1998022579A1 Insulin-like growth factor 1 receptor (igf-1r) antisense oligonucleotide-treated breast cancer cells composition |
05/28/1998 | WO1998022575A2 Nucleotide sequence of escherichia coli pathogenicity islands |
05/28/1998 | WO1998022506A1 Human kdel receptor |
05/28/1998 | WO1998022149A1 Method for treating neoplasia using humanized antibodies which bind to antigen a33 |
05/28/1998 | WO1998022145A1 Immunization of infants |
05/28/1998 | WO1998022138A1 Method for treating symptoms of diabetes |
05/28/1998 | WO1998022137A1 SUPPRESSION OF TNF α AND IL-12 IN THERAPY |
05/28/1998 | WO1998022136A2 Stable lyophilized pharmaceutical substances from monoclonal or polyclonal antibodies |
05/28/1998 | WO1998022133A1 NOVEL FabD |
05/28/1998 | WO1998022100A2 New use for 1,3-propanediol derivatives |
05/28/1998 | WO1998021951A1 Methods and compositions for inducing oral tolerance in mammals |
05/28/1998 | WO1998001550A3 Vaccine against gastro-intestinal nematodes |
05/28/1998 | DE19648687A1 Composition containing immunomodulatory peptide or protein and adjuvant |
05/28/1998 | CA2633660A1 Method for treating symptoms of diabetes |
05/28/1998 | CA2275438A1 Improved methods for transducing cells |
05/28/1998 | CA2272824A1 Insulin-like growth factor 1 receptor (igf-1r) antisense oligonucleotide-treated breast cancer cells composition |
05/28/1998 | CA2272093A1 Method for treating neoplasia using humanized antibodies which bind to antigen a33 |
05/28/1998 | CA2272047A1 Nucleotide sequence of escherichia coli pathogenicity islands |
05/28/1998 | CA2271783A1 Survivin, a protein that inhibits cellular apoptosis, and its modulation |
05/28/1998 | CA2270407A1 Human kdel receptor |
05/28/1998 | CA2243643A1 Methods and compositions for inducing oral tolerance in mammals |
05/27/1998 | EP0844307A1 Candida albicans protein caYAE1 |
05/27/1998 | EP0844305A2 hRAD54 |
05/27/1998 | EP0843818A1 Lawsonia intracellularis cultivation, anti-lawsonia intracellularis vaccines and diagnostic agents |
05/27/1998 | EP0843583A1 Golf club receptacle |
05/27/1998 | EP0843557A1 Methods for detecting, identifying, isolating, and selectively labelling and targeting th1 lymphocytes by means of the lag-3 protein |
05/27/1998 | EP0596032B1 Induction of cytotoxic t-lymphocyte responses |
05/27/1998 | CN1183117A Intracelluar domain of the HER-2/neu protein for prevention or treatment of malignancies |
05/27/1998 | CN1183046A Composition of tyrosine and polymerised allergen |
05/27/1998 | CN1183043A Preparation and use of sulfated oligosaccharides |
05/27/1998 | CA2216625A1 Novel compounds |
05/26/1998 | US5756687 Isolation of components of interest from milk |
05/26/1998 | US5756682 Antibodies that bind specifically to polypeptide |
05/26/1998 | US5756674 Fusion proteins |
05/26/1998 | US5756666 Peptides capable of inducing immune response to HIV |
05/26/1998 | US5756664 Genetic engineering of proteins with nucleotide sequences for bones |
05/26/1998 | US5756662 Detecting trypanosoma infection by contacting biological sample with specified polypeptide, detecting presence of antibodies binding thereto |
05/26/1998 | US5756448 Constitute activator of retinoid (CAR) receptor polypeptides |
05/26/1998 | US5756353 Introducing dna into cell of proximal or distal airways of a mammal by administering aerosol lipid-dna complex |
05/26/1998 | US5756349 Culture of cells and radioimmunoassay |
05/26/1998 | US5756343 Cell stress transcriptional factors |
05/26/1998 | US5756342 Monoclonal antibody or antigen binding fragment thereof, capable of blocking suppression of gamma-interferon |
05/26/1998 | US5756341 Culturing monkey kidey cells in serum-free medium, infecting with influenza virus having modified cleavage site, incubating to produce antigen, removing portion, contacting with protease which activates virus, adding inhibitor, returning to culture |
05/26/1998 | US5756330 Glycyl tRNA synthetase polynucleotides of streptococcus |
05/26/1998 | US5756329 DNA encoding phenylalanyl tRNA synthetase from Staphylococcus aureus |
05/26/1998 | US5756323 Genetic engineering |
05/26/1998 | US5756312 Dna molecule encoding polypeptide comprising two heterogeneous amino acid sequences from same variable domain of hepatitis c virus isolates |
05/26/1998 | US5756310 Culture product |
05/26/1998 | US5756284 Self-assembling recombinant papillomavirus capsid proteins |
05/26/1998 | US5756281 Stealth virus detection in the chronic fatigue syndrome |
05/26/1998 | US5756264 Expression vector systems and method of use |
05/26/1998 | US5756105 Vaccine for prevention of hemophilus influenzae infection |
05/26/1998 | US5756104 Liposome-containing intranasal vaccine formulation |
05/26/1998 | US5756103 Alvac canarypox virus recombinants comprising heterlogous inserts |
05/26/1998 | US5756102 Poxvirus-canine distemper virus (CDV) recombinants and compositions and methods employing the recombinants |
05/26/1998 | US5756101 Malaria recombinant poxvirus |
05/26/1998 | US5756097 Immunotherapeutic treatment of cancer |
05/26/1998 | US5756095 Immunoassays for detection of adhesion molecules |
05/26/1998 | US5756084 Human stromal derived factor 1α and 1β |
05/25/1998 | CA2216622A1 Novel compounds |
05/25/1998 | CA2215929A1 Novel lep |
05/22/1998 | WO1998021364A2 Method and apparatus for preparing sample cartridges for a particle acceleration device |
05/22/1998 | WO1998021359A1 Glutathione s-transferase (gst) genes in cancer |
05/22/1998 | WO1998021354A1 Poxvirus-based expression vectors containing heterologous inserts derived from lentiviruses |
05/22/1998 | WO1998021344A1 Chimeric ltb vaccines |
05/22/1998 | WO1998021343A1 Genes encoding telomerase proteins |
05/22/1998 | WO1998021338A1 Synthesis and purification of hepatitis c virus-like particles |
05/22/1998 | WO1998021337A2 C3 BINDING PROTEIN OF $i(STREPTOCOCCUS PNEUMONIAE) |
05/22/1998 | WO1998021331A1 Human breast tumor-specific proteins |
05/22/1998 | WO1998021327A1 Peptides capable of inhibiting the endocytosis of the app and corresponding nucleotide sequences |
05/22/1998 | WO1998021324A1 Novel carboxylesterase nucleic acid molecules, proteins and uses thereof |
05/22/1998 | WO1998021243A1 Method and novel compounds for use therein |